These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9754251)

  • 21. [Cholera].
    Sagara H
    Ryoikibetsu Shokogun Shirizu; 1999; (23 Pt 1):138-41. PubMed ID: 10088357
    [No Abstract]   [Full Text] [Related]  

  • 22. Diarrhea in a renal allograft recipient in the tropics.
    Sundaram M; Veeraraghavan B; John GT
    Transplantation; 2008 Feb; 85(4):656. PubMed ID: 18347550
    [No Abstract]   [Full Text] [Related]  

  • 23. Acute secretory traveller's diarrhoea caused by Vibrio cholerae which does not belong to the O1 or O139 serogroup.
    Bhattacharya MK; Dutta D; Deb A; Garg P; Chakraborty S; Mukhopadhyay AK; Bhattacharya SK; Moitra A
    Natl Med J India; 1998; 11(5):248-9. PubMed ID: 10997178
    [No Abstract]   [Full Text] [Related]  

  • 24. [Septicemia caused by Vibrio cholerae non-01 in immunocompromised patient].
    Calduch Broseta JV; Segarra Soria MM; Colomina Avilés J; Llorca Ferrandiz C; Pascual Pérez R
    An Med Interna; 2003 Dec; 20(12):630-2. PubMed ID: 14697085
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of intravenous somatostatin on stool output in diarrhea due to Vibrio cholerae.
    Molla AM; Gyr K; Bardhan PK; Molla A
    Gastroenterology; 1984 Oct; 87(4):845-7. PubMed ID: 6147293
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emergence of tetracycline-resistant Vibrio cholerae O1 serotype Inaba, in Kolkata, India.
    Roychowdhury A; Pan A; Dutta D; Mukhopadhyay AK; Ramamurthy T; Nandy RK; Bhattacharya SK; Bhattacharya MK
    Jpn J Infect Dis; 2008 Mar; 61(2):128-9. PubMed ID: 18362401
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Antibiotic susceptibility of Vibrio cholerae 01: evolution after prolonged curative and preventive use during the 2004 cholera epidemics in Douala (Cameroon)].
    Guévart E; Solle J; Mouangue A; Noeske J; Bita A; Fonkoua MC; Ndayo Wouafo M
    Med Mal Infect; 2006 Jun; 36(6):329-34. PubMed ID: 16757139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Shellfish-acquired Vibrio cholerae cellulitis and sepsis from a vulnerable leg.
    Whittaker SJ
    N Z Med J; 2013 Aug; 126(1379):95-7. PubMed ID: 24045356
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A fatal non-01 Vibrio cholerae septicemia in a patient with liver cirrhosis.
    Eltahawy AT; Jiman-Fatani AA; Al-Alawi MM
    Saudi Med J; 2004 Nov; 25(11):1730-1. PubMed ID: 15573214
    [No Abstract]   [Full Text] [Related]  

  • 30. Bacteriological profile and changing antibiograms of Vibrio cholerae isolated in east Delhi, 1998-2003.
    Chowdhary B; Das S; Arora R; Mathur M
    J Commun Dis; 2004 Jun; 36(2):147-51. PubMed ID: 16295679
    [No Abstract]   [Full Text] [Related]  

  • 31. Serotypes and phage types of Vibrio cholerae in Mysore.
    Hanumanthappa AR; Rajagopal V
    J Commun Dis; 2000 Dec; 32(4):313-5. PubMed ID: 11668944
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tetracycline resistant cholera in Kelantan.
    Ranjit K; Nurahan M
    Med J Malaysia; 2000 Mar; 55(1):143-5. PubMed ID: 11072502
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Otitis caused by Vibrio cholerae non-01/non-0139 strains acquired in Germany].
    Handrick W; Schwede J; Schulz K; Fitz FP; Pommerenke G; Reintanz G
    MMW Fortschr Med; 2004 Jul; 146(27-28):38-9. PubMed ID: 15526661
    [No Abstract]   [Full Text] [Related]  

  • 34. Changing characteristics of Vibrio cholerae: emergence of multidrug resistance and non-O1, non-O139 serogroups.
    Chandrasekhar MR; Krishna BV; Patil AB
    Southeast Asian J Trop Med Public Health; 2008 Nov; 39(6):1092-7. PubMed ID: 19062701
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-O1/non-O139 Vibrio cholerae septicemia with peritonitis.
    Wiwatworapan W; Insiripong S
    Southeast Asian J Trop Med Public Health; 2008 Nov; 39(6):1098-101. PubMed ID: 19062702
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cholera vaccine will reduce antibiotic use.
    Okeke IN
    Science; 2009 Aug; 325(5941):674. PubMed ID: 19661401
    [No Abstract]   [Full Text] [Related]  

  • 37. Vibrio cholerae 01 strain resistant to vibriostatic compound 0/129 isolated from cholera cases in Kilifi, Kenya.
    Khamala JK; Mwarumba S; Lewa P; Lowe B
    East Afr Med J; 2002 Oct; 79(10):560. PubMed ID: 12635766
    [No Abstract]   [Full Text] [Related]  

  • 38. [Cases of imported cholera in France, summer 2005. A. Tarantola for the incident management teams].
    ; Ajzenman C; Bizet MC; Dufraisse MP; Falip E; Fournier JM; Etchegorry MG; Haeghebaert S; Isnard H; Le Loc'h H; Mansir T; Quilici ML; Raqbi F; Raud E; Roberto Y; Scanvic A; Senellier M; Sirot S; Tarantola A
    Med Mal Infect; 2006 Jun; 36(6):346-8. PubMed ID: 16806780
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A cholera epidemic in a rural area of northeast India.
    Phukan AC; Borah PK; Biswas D; Mahanta J
    Trans R Soc Trop Med Hyg; 2004 Sep; 98(9):563-6. PubMed ID: 15251406
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical profile of non-O1 strain-O139 of Vibrio cholerae in the region of Ambajogai, Maharashtra.
    Kamble TK; More SR; Chavan SS; Kulkarni ND; Lodha NS; Kamble AS
    J Assoc Physicians India; 2000 May; 48(5):505-6. PubMed ID: 11273144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.